2m 2m 2m 2m 2m 2m 2m
APIMEDS PHARMA (APUS)
NYSE
$2.14+$0.03 (+1.43%)
Price as of Sep 11, 2026 7:05 PM EDT- $3.2MMarket Cap
- -89.88%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
APIMEDS PHARMA (APUS)
$2.14+$0.03 (+1.43%)
APUS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.10 | ||
Change | -$0.06 (-3.00%) | ||
Open | $2.16 | ||
High | $2.26 | ||
Low | $2.09 | ||
Previous Close | $2.17 | ||
Volume | 20,691 | ||
30-Day Average Volume | 155,645 | ||
1-Week Change | -13.02% | ||
1-Month Change | -54.54% | ||
1-Year Change | -89.88% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 1.5M | ||
Total Assets | $127.6M | ||
Market Cap | $3.2M | ||
Enterprise Value | $24.6M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$20.2M | ||
Free Cash Flow | -$5.7M | ||
EBIT | -$18.4M | ||
EBITDA | -$18.3M | ||
Net Working Capital | -$10.4M | ||
EPS | -$117.70 | ||
Enterprise Value/EBITDA | -1 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 0 | ||
P/E | -0 | ||
PEG | 0 | ||
Price/Free Cash Flow | -1 | ||
Price/Operating Cash Flow | -1 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 07/24/2026 | ||
Earnings & Revenue